StockWatch
·
Pharmaceuticals
Project Update19 Nov 2026, 12:34 pm

Mercury Labs Delays Parenteral Plant Operations by 12 Months

AI Summary

Mercury Laboratories Ltd has announced a 12-month delay in the commencement of commercial operations for its new Small Volume Parenteral (SVP) manufacturing facility at Unit No 2, Baroda - Halol Road, Jarod. The expected operational date has been revised from December 2026 to December 2027. This revision is attributed to evolving regulatory requirements, including the implementation of revised Schedule M requirements and alignment with international Good Manufacturing Practices (GMP). The company stated that additional technical and compliance measures necessitated this timeline adjustment to ensure the facility meets requisite quality, safety, and manufacturing standards. Mercury Laboratories remains committed to completing the project systematically.

Key Highlights

  • Parenteral plant operations delayed by 12 months.
  • New commercial operations expected by December 2027.
  • Delay due to evolving regulatory and GMP compliance needs.
  • Company committed to systematic project completion.